BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Treatment
13410 results:

  • 1. Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study.
    Fleischmann R; Swierkot J; Penn SK; Durez P; Bessette L; Bu X; Khan N; Li Y; Peterfy CG; Tanaka Y; Mysler E
    RMD Open; 2024 May; 10(2):. PubMed ID: 38806190
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Malignant melanoma in a 12-year-old boy 17 months after completing hepatoblastoma treatment.
    Kanezawa K; Yagasaki H; Arakawa A; Hoshi R; Uehara S; Morioka I
    Cancer Rep (Hoboken); 2024 May; 7(5):e2118. PubMed ID: 38801212
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Silver Complexes of Miconazole and Metronidazole: Potential Candidates for Melanoma treatment.
    Fabijańska M; Rybarczyk-Pirek AJ; Dominikowska J; Stryjska K; Żyro D; Markowicz-Piasecka M; Szynkowska-Jóźwik MI; Ochocki J; Sikora J
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791121
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma.
    Wu Z; Zhang R; Bao J; Yin M; Wang X
    Arch Dermatol Res; 2024 May; 316(6):219. PubMed ID: 38787413
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The efficacy and tolerability of bortezomib, thalidomide, and dexamethasone induction therapy with a thalidomide dose step-up strategy in patients with newly diagnosed multiple myeloma: A prospective observational study.
    Liao PW; Lu HJ; Chen TC; Lin HC; Shih YH; Teng CJ
    Cancer Rep (Hoboken); 2024 May; 7(5):e2102. PubMed ID: 38775249
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.
    Hwang A; Kwon A; Miller CH; Reimer-Taschenbrecker A; Paller AS
    Orphanet J Rare Dis; 2024 May; 19(1):206. PubMed ID: 38769503
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mortality trend of cutaneous melanoma in Montenegro from 1990-2018.
    Nedovic Vukovic M; Terzic Z; Golubovic M; Bojic M; Bukumiric Z
    Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3463-3472. PubMed ID: 38766804
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
    Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
    Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients.
    Song H; Hu Z; Zhang S; Yang L; Feng J; Lu L; Liu Y; Wang T
    J Dermatolog Treat; 2024 Dec; 35(1):2350231. PubMed ID: 38754985
    [No Abstract]    [Full Text] [Related]  

  • 10. Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.
    Bang AS; Said JT; Hirner J; Rana J; Pugliese S; Wang JY; Zaba L; Zhao L; Doan L; Smith J; Kwong BY
    Support Care Cancer; 2024 May; 32(6):354. PubMed ID: 38750379
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design.
    Gogineni E; Chen H; Hu C; Boudadi K; Engle J; Levine A; Deville C
    Radiat Oncol; 2024 May; 19(1):56. PubMed ID: 38745333
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study.
    D'Angelo SP; Lebbé C; Mortier L; Brohl AS; Fazio N; Grob JJ; Prinzi N; Hanna GJ; Hassel JC; Kiecker F; von Heydebreck A; Güzel G; Nghiem P
    ESMO Open; 2024 May; 9(5):103461. PubMed ID: 38744102
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in
    Zhang H; Read A; Cataisson C; Yang HH; Lee WC; Turk BE; Yuspa SH; Luo J
    Sci Signal; 2024 May; 17(836):eadd5073. PubMed ID: 38743809
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors' perspective.
    Kähler KC; Gutzmer R; Angela Y; Livingstone E; Lodde G; Meiss F; Rafei-Shamsabadi DA; Weyer-Fahlbusch SS; Nashan D; Loquai C; Hassel JC; Sachse MMM; Maul LV; Heinzerling L; Heppt MV; Colapietro C; Rusch J; Blome C
    J Cancer Res Clin Oncol; 2024 May; 150(5):252. PubMed ID: 38743104
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Predicting the effectiveness of organ-preserving treatment of choroidal melanoma using optical coherence tomography data].
    Stoyukhina AS
    Vestn Oftalmol; 2024; 140(2. Vyp. 2):16-20. PubMed ID: 38739126
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Based on Immune Microenvironment and Genomic Status, Exploring Immunotherapy in Advanced Hidradenocarcinoma: A Retrospective Analysis.
    Lin J; Zhu L; Chen Y; Li Q; Ke Z; Zhang H; Huang Y; Lu J; Chen Y
    Acta Derm Venereol; 2024 May; 104():adv22146. PubMed ID: 38738772
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Outcomes of the Transungual Approach in 56 Consecutive Digital Subungual Glomus Tumours.
    Biswas D; Sikdar S; Islam T
    J Hand Surg Asian Pac Vol; 2024 Jun; 29(3):240-247. PubMed ID: 38726497
    [No Abstract]    [Full Text] [Related]  

  • 18. COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma.
    Schadendorf D; Dummer R; Flaherty KT; Robert C; Arance A; de Groot JWB; Garbe C; Gogas HJ; Gutzmer R; Krajsová I; Liszkay G; Loquai C; Mandalà M; Yamazaki N; Queirolo P; Guenzel C; Polli A; Thakur M; di Pietro A; Ascierto PA
    Eur J Cancer; 2024 Jun; 204():114073. PubMed ID: 38723373
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Monitoring Adolescent and Young Adult Patients With cancer via a Smart T-Shirt: Prospective, Single-Cohort, Mixed Methods Feasibility Study (OncoSmartShirt Study).
    Steen-Olsen EB; Pappot H; Hjerming M; Hanghoej S; Holländer-Mieritz C
    JMIR Mhealth Uhealth; 2024 May; 12():e50620. PubMed ID: 38717366
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The Application of "Table Tennis Racquet" Random skin Flap in the treatment of Facial skin Carcinoma.
    Tian K; Jia Z; Xu W; Wang X; Xie X; Gu Y; Cao S; Gao S; Li K; Wu L
    Ann Plast Surg; 2024 Jun; 92(6):647-652. PubMed ID: 38717142
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 671.